Liu et al. [23] highlighted the absence of ATRX within secondary glioblastomas, and more particularly in younger patients, whereas Cai et al. [24] observed a higher rate of lower ATRX expression in primary GBM and grade III gliomas than in grade II gliomas, and suggested this as a malignancy marker. The gene discussed is ATRX; the disease is glioblastoma.